Zobrazeno 1 - 10
of 105
pro vyhledávání: '"Keiko Katayama"'
Autor:
Chikako Yamamoto, Shintaro Nagashima, Channarena Chuon, Ko Ko, Son Huy Do, Oline Lim, Sirany Hok, Somana Svay, Junko Matsuo, Keiko Katayama, Kazuaki Takahashi, Junko Tanaka
Publikováno v:
Viruses, Vol 12, Iss 5, p 551 (2020)
The high genetic variability of hepatitis C virus (HCV) is the main obstacle to developing a vaccine. E2 has attracted attention for vaccine development because targeting this protein could potentially overcome issues related to the genetic diversity
Externí odkaz:
https://doaj.org/article/967f448c03564bfba134448103b4867f
Autor:
Junko Matsuo, Son Huy Do, Chikako Yamamoto, Shintaro Nagashima, Channarena Chuon, Keiko Katayama, Kazuaki Takahashi, Junko Tanaka
Publikováno v:
PLoS ONE, Vol 12, Iss 7, p e0177248 (2017)
Vietnam has a high rate of hepatitis B virus (HBV) infection and a high mortality rate from hepatocellular carcinoma. We performed a detailed genetic analysis of 48 residents and four families from Binh Thuan Province, a southern coastal area of Viet
Externí odkaz:
https://doaj.org/article/515496706766405a8a409354d5dece26
Autor:
Hiroko Yamada, Kazuaki Takahashi, Olline Lim, Somana Svay, Channarena Chuon, Sirany Hok, Son Huy Do, Mayumi Fujimoto, Tomoyuki Akita, Noboru Goto, Keiko Katayama, Masahiro Arai, Junko Tanaka
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0136903 (2015)
Hepatitis E virus (HEV) is a growing public health problem in many countries. In this study, we investigated HEV seroprevalence among the general population in the Siem Reap province, Cambodia, and performed HEV genetic analysis with the aim to devel
Externí odkaz:
https://doaj.org/article/baf82871865a44479b197201e40ce178
Autor:
Yuka Hirai, Yuko Hamada, Shun Sasaki, Marie Suzuki, Yuta Ito, Keiko Katayama, Hirokazu Uno, Tokio Nakada, Yuki Kitami, Keisuke Uchida, Yoshinobu Eishi, Hirohiko Sueki
Publikováno v:
Journal of Cutaneous Pathology. 49:651-657
Autor:
Junko Tanaka, Aya Sugiyama, Masayuki Ohisa, Tomoyuki Akita, Shintaro Nagashima, Ryo Maeda, Kingo Fujimura, Keiko Katayama
Publikováno v:
International Journal of Hematology. 113:576-585
Monoclonal gammopathy (M-proteinemia) is a premalignant plasma cell disorder. The prevalence of M-proteinemia increases with age and is affected by genetic or environmental factors. Atomic bomb (A-bomb) survivors in Hiroshima are in an age range when
Autor:
Keiko Katayama, Junko Tanaka, Ko Ko, Masayuki Ohisa, Channarena Chuon, Shintaro Nagashima, Chikako Yamamoto, Masaharu Yoshihara, Aya Sugiyama, Tomoyuki Akita
Publikováno v:
Vaccine. 37:145-151
Background Health care workers (HCWs) are at high risk of contracting blood-borne infections including hepatitis B virus (HBV) infection. In Japan, all HCWs are required to receive HB vaccination before beginning work. This study aimed to investigate
Autor:
Kingo, Fujimura, Aya, Sugiyama, Tomoyuki, Akita, Masayuki, Ohisa, Shintaro, Nagashima, Keiko, Katayama, Ryo, Maeda, Junko, Tanaka
Publikováno v:
International journal of hematology. 113(4)
Monoclonal gammopathy (M-proteinemia) is a premalignant plasma cell disorder. The prevalence of M-proteinemia increases with age and is affected by genetic or environmental factors. Atomic bomb (A-bomb) survivors in Hiroshima are in an age range when
Autor:
Jamshid Matyakubov, Masayuki Ohisa, Ko Ko, Kazuaki Takahashi, Junko Matsuo, Chikako Yamamoto, Takao Masaki, Shintaro Nagashima, Ulugbek Mirzaev, Tomoyuki Akita, Keiko Katayama, Junko Tanaka
Publikováno v:
Journal of medical virologyREFERENCES.
This study aimed to investigate the prevalence trend of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections and their genotype distribution among hemodialysis patients, determining their long-term prognosis and the risk factors to the mort
Autor:
Junko Tanaka, Chikako Yamamoto, Ko Ko, Channarena Chuon, Kazuaki Takahashi, Somana Svay, Oline Lim, Keiko Katayama, Shintaro Nagashima, Junko Matsuo, Son Huy Do, Sirany Hok
Publikováno v:
Viruses, Vol 12, Iss 551, p 551 (2020)
Viruses
Volume 12
Issue 5
Viruses
Volume 12
Issue 5
The high genetic variability of hepatitis C virus (HCV) is the main obstacle to developing a vaccine. E2 has attracted attention for vaccine development because targeting this protein could potentially overcome issues related to the genetic diversity
Autor:
Tomoyuki Akita, Md. Shafiqul Hossain, Kazuaki Takahashi, Ko Ko, Chikako Yamamoto, Channarena Chuon, Mitsuo Isomura, Shintaro Nagashima, Junko Tanaka, Keiko Katayama, Joseph Woodring
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-10 (2020)
Scientific Reports
Scientific Reports
Although hepatitis B (HBV) and C (HCV) virus infections are still global health issues, measuring sero-markers by standard venipuncture is challenging in areas limited with the adequate human resources and basic infrastructure. This study aimed to in